AORT vs LUNG

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 12, 2026

AORT

48.0
AI Score
VS
LUNG Wins

LUNG

49.6
AI Score

Investment Advisor Scores

AORT

48score
Recommendation
HOLD

LUNG

50score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric AORT LUNG Winner
Forward P/E 37.8788 28.3286 LUNG
PEG Ratio 181.5 0 Tie
Revenue Growth 11.3% -4.6% AORT
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 48.0/100 49.6/100 LUNG
Profit Margin -0.7% -55.0% AORT
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

AORT 1M: -12.4% · 3M: +21.7% LUNG 1M: -19.2% · 3M: +30.3%

Current Technical Phase

AORT

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 41

RSI (14): 40.6 · Price: $25.08

LUNG

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 38

RSI (14): 37.6 · Price: $1.85

Fundamentals Snapshot

Metric AORT LUNG
Market Cap
Forward P/E 33.5 -2.0
Trailing P/E
Revenue (TTM)
Revenue Growth 0.1% 0.0%
Gross Margin 0.6% 0.8%
Operating Margin 0.1% -0.4%
EPS -0.06 -1.15
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, LUNG is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.